Regunac DR 75mg Capsule
By Regunac
Rx
10 Capsule in a Strip

Composition
Diclofenac(75mg)

Manufacturer - Unijules Life Science Ltd
MIDC INDUSTRIAL AREA, KALMESHWAR, DIST.: NAGPUR-441501 (M.S.) INDIA

Expires on or after
October, 2025

liver
When using Regunac DR 75mg Capsule, it is important to be cautious if you have liver disease. It may be necessary to adjust the dose of the capsule, so it is crucial to consult with your doctor before using this medication. Regular monitoring of liver function tests is advised for patients with liver issues, especially if you are planning to take Regunac DR 75mg Capsule for an extended period. This monitoring helps ensure the safety and effectiveness of the treatment.

kidney
Regunac DR 75mg Capsule should be used carefully in kidney disease patients. Dosage adjustment may be necessary. Consult your doctor.

alcohol
It is advised not to drink alcohol while taking Regunac DR 75mg Capsule.

driving
Regunac DR 75mg Capsule may lead to side effects like headaches, blurred vision, dizziness, or drowsiness, impacting driving ability.

pregnancy
Regunac DR 75mg Capsule is not recommended during pregnancy due to potential risks to the developing baby. It may be prescribed in life-threatening situations only if benefits outweigh risks. Always consult your doctor before use in pregnancy.

breastfeeding
Regunac DR 75mg Capsule is considered safe during breastfeeding based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | Phenylacetic acid Derivative |
Therapeutic Class | PAIN ANALGESICS |
Action Class | NSAID's- Non-Selective COX 1&2 Inhibitors (acetic acid) |
₹40
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025